PRELUDE CAPITAL MANAGEMENT, LLC

Position in IQV — Iqvia Holdings Inc.

CIK 1387508 NEW YORK, NY

Position in IQV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$876,234

-$323,848 QoQ

Shares Held

5,138

-3.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $9,521,154 across 13 Diagnostics & Research names. IQV ranks #6 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SHC	Sotera Health Co	108,608	$1,557,438
2	GH	Guardant Health, Inc.	16,636	$1,536,667
3	NTRA	Natera, Inc.	5,676	$1,135,143
4	TWST	Twist Bioscience Corp	21,687	$1,030,566
5	FLGT	Fulgent Genetics, Inc.	56,309	$895,313
6	IQV	Iqvia Holdings Inc. This page	5,138	$876,234
7	DHR	Danaher Corp /De/	2,693	$510,592
8	TMO	Thermo Fisher Scientific Inc.	836	$410,919

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$876,234	5,138	-3.5%	Shares	Other	2026-05-15
2025-12-31	$1,200,082	5,324	+211.2%	Shares	Other	2026-02-17
2025-09-30	$324,987	1,711	+8.1%	Shares	Other	2025-11-14
2025-06-30	$249,464	1,583	+31.6%	Shares	Other	2025-08-14
2025-03-31	$212,088	1,203	-53.0%	Shares	Other	2025-05-15
2024-09-30	$606,880	2,561	+42.3%	Shares	Other	2024-11-14
2024-06-30	$380,592	1,800	+82.6%	Shares	Other	2024-08-14
2024-03-31	$249,349	986	+18.9%	Shares	Other	2024-05-15
2021-12-31	$233,894	829	-20.7%	Shares	Other	2022-02-14
2021-09-30	$250,319	1,045	-69.3%	Shares	Sole	2021-11-15
2021-06-30	$824,857	3,404	-20.8%	Shares	Sole	2021-08-16
2021-03-31	$830,502	4,300	+168.8%	Shares	Other	2021-05-17
2020-09-30	$252,208	1,600	—	Shares	Other	2020-11-16
No filing history on record for this holder in this stock.